LUNG FY 2021 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$48M+47.9% YoY

Gross Profit

$36M73.6% margin

Operating Income

-$47M-97.7% margin

Net Income

-$49M-100.5% margin

EPS (Diluted)

$-1.35

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$45M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$235M

Total Liabilities

$42M

Stockholders' Equity

$193M

Cash & Equivalents

$148M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$33M	+47.9%
Gross Profit	$36M	$21M	+68.1%
Operating Income	-$47M	-$32M	-46.3%
Net Income	-$49M	-$32M	-51.0%